JPRN-UMIN000010813招募中未知
A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of oral administration of probiotic LKM512 in individuals with pre-arteriosclerosis - Effects of probiotics LKM512 in individuals with pre-arteriosclerosis: double-blind, placebo-controlled parallel group study
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Subjects who are undergoing dyslipidemia treatment (2)Subjects who take medicine that influencea value of cholesterol (3)Seriouse subjects who have complications with cardiac disease, hepatic disease, and/or renal disease (4)Subjects who was enrolled in other trails within three month. (5)Inappropriate cases evaluated by doctors
研究者
相似试验
已完成
不适用
A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of yogurt containing probiotic LKM512 and arginine on function of vascular endothelium and intestinal environmentJPRN-UMIN000023857Kyodo Milk Industry Co. Ltd.40
已完成
不适用
A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of oral administration of probiotic LKM512 and arginine on function of vascular endothelium in individuals with pre-metabolic syndromepre-metabolic syndromeJPRN-UMIN000015352Kyodo Milk Industry Co. Ltd.40
已完成
2 期
A Randomized, double blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of CNP520 in healthy elderly subjectsAlzheimer diseasealzheimer diseasedementiaNL-OMON42784ovartis30
进行中（未招募）
1 期
An international study assessing the efficacy of a new drug (S 066913) in paroxysmal atrial fibrillatioMedDRA version: 18.0Level: LLTClassification code 10034039Term: Paroxysmal atrial fibrillationSystem Organ Class: 100000004849Paroxysmal Atrial FibrillationEUCTR2014-002333-63-CZInstitut de Recherches Internationales Servier160
已完成
2 期
A randomized, double blind, placebo-controlled, parallel, international multicenter study assessing the efficacy of S066913 in patients with paroxysmal atrial fibrillation. Double-blind, International study AssessinG efficacy of S066913 in paRoxysmal Atrial Fibrillation -IKur inhibitor (DIAGRAF - IKUR)paroxysmal atrial fibrillationNL-OMON41862Institut de Recherches Internationales Servier I.R.I.S34